BENDER JOHN A has a total of 11 patent applications. Its first patent ever was published in 1916. It filed its patents most often in United States, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and civil engineering are VALO EARLY DISCOVERY INC, MITOKININ INC and CUMBRE PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | Canada | 1 | |
#3 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Civil engineering |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Machines for making railways |
# | Name | Total Patents |
---|---|---|
#1 | Bender John A | 11 |
#2 | Kadow John F | 6 |
#3 | Yang Zhong | 4 |
#4 | Belema Makonen | 3 |
#5 | Hewawasam Piyasena | 3 |
#6 | Lopez Omar D | 2 |
#7 | Wang Gan | 2 |
#8 | Gentles Robert G | 1 |
#9 | Meanwell Nicholas A | 1 |
#10 | Grant-Young Katharine A | 1 |
Publication | Filing date | Title |
---|---|---|
US2013028859A1 | Hepatitis C virus inhibitors | |
US2011077280A1 | Hepatitis C virus inhibitors | |
US2010216774A1 | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors | |
US2011014154A1 | Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors | |
US2009130056A1 | Compounds for the treatment of Hepatitis C | |
CA180158A | Tie bar for rails | |
US1230370A | Tie-bar for rails. |